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Abstract
Purpose of Review To summarise findings about the prevalence and correlates of challenging behaviour in adults with intellec-
tual disabilities from robust research. We also describe findings on the interplay between challenging behaviour and mental
health.
Recent Findings Recent studies that have utilised psychometrically evaluated tools, with clear operational definitions, show
similar findings on the prevalence of challenging behaviour of about 1 in every 5–6 adults known to services. We describe
common correlates identified such as communication impairments, severity of intellectual disability, and living in institutional
settings or congregate care. We also describe the complex and multifaceted relationship between challenging behaviour and
mental health.
Summary Based on recent studies, we propose a revised framework model to help understand challenging behaviour. We
propose a number of areas where more research is required, particularly the development of risk tools clinicians can utilise in
practice.
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Introduction
There is a high prevalence of challenging behaviour (CB) [1•,
2, 3••] and mental health (MH) issues [4, 5•] in adults with
intellectual disabilities (ID). For adults with ID, CB can lead to
negative personal outcomes and diminished quality of life [6].
It can result in poor integration, exclusion from services, limit
friendships, and interfere with learning and development [7,
8]. Studies have shown that CB may lead to long-term inpa-
tient care with an associated increased risk of physical harm
and abuse [6, 9]. CB can also lead to an increased reliance on
restrictive practices such as seclusion or restraint [10–12], and
results in negative consequences for carers, including risks of
physical harm and psychological distress [7, 13].
In this paper, we review literature on the prevalence of CB
in adults with ID. We will examine factors that have been
correlated with CB, explore the differences between correlates
and risk factors, and consider the cumulative impact of risk
factors. We will discuss the complex and multi-faceted rela-
tionship between CB and MH issues. Based on a review of
recent studies, we propose a revised framework model for CB
[14••] that includes reference to MH issues, updates vulnera-
bility factors, and refers to the impact of increased psychotro-
pic medication use.
Prevalence of Challenging Behaviour
in Adults with ID
Understanding the prevalence of CB in adults with ID is im-
portant for service planning and resource funding. Research
on the prevalence of CB in individuals with ID to date has
been largely restricted to a focus on specific clinical popula-
tions in specific clinical settings [6]. Reported prevalence
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shows considerable variation between 4–22% in previous to-
tal population studies [1•, 8], to as high as 50–80% in studies
looking at specific settings, subpopulations, or behaviours
[15, 16].
The most robust methodology to estimate prevalence of
CB is to sample at the population level. Some variation in
population studies can be explained by differences in study
designs and methodologies (for summaries see 1, 7). CB has
been a particularly difficult variable to define consistently and
validly [17]. Some earlier studies (e.g., 18) attempted to dis-
criminate between CB that is “more” or “less” demanding.
“More demanding” CB was defined as occurring daily,
restricting engagement, requiring physical intervention, or
causing injury. Using this definition, prevalence estimates
for CB varies between 3.8 and 10% [6, 8, 18–20]. Studies that
included “less demanding” CB (problem behaviour including
aggression, destruction, or self-injury which did not meet the
“more demanding” criteria) had increased prevalence esti-
mates of 10–15% [6, 8].
A number of studies have been restricted in their sampling
methods by extracting data from sources not designed to hold
quantifiable data, such as clinicians’ notes (e.g., [21, 22, 23•]),
or by postal surveys utilising numerous informants who may
lack precise information regarding the occurrence of CB (e.g.,
[24]). In a previous meta-analysis [25] exploring risk factors
in CB studies, only 22 of the 86 studies considered were found
to contain enough information to be included, fewer than half
of these used a questionnaire type instrument, and very few
any psychometrically evaluated tools. There have been few
robust, population studies that have estimated prevalence of
CB utilising psychometrically evaluated assessment and clas-
sification tools developed specifically for adults with ID [1•].
In a 2017 study [3••], Bowring, Totsika, Hastings,
Toogood, and Griffith used a definition of CB derived from
ratings on the Behaviour Problems Inventory–Short Form
[26] in a total population sample of adults with ID in Jersey.
This study revealed a prevalence rate of CB of 18.1% (95%
CI, 13.94–23.19%) which was similar to other population
studies that had used classification tools for adults with ID–
18.7% [1•, 2]. The Bowring et al. study also examined the
prevalence of sub-types of CB data that have often been miss-
ing in earlier population studies. The prevalence of aggressive
and destructive behaviour (ADB) was 8.3% (95% CI, 5.54–
12.25%), self-injurious behaviour (SIB) 7.5% (95% CI, 4.94–
11.37%), and stereotyped behaviour (SB) 10.9% (95% CI,
7.73–15.27%) [3••]. Prevalence of SB has only been reported
in one other population study studies [2] and given potential
impact on quality of life requires further research. Other stud-
ies have similarly found ADB to be more prevalent than SIB
(e.g., ADB 9.8%, SIB 4.9% [7]; ADB 11.9%, SIB 8.4% [2]).
In summary, the reported prevalence of CB in historical
studies (e.g., [8, 16]) shows considerable variation (4–80%)
with much of this due to the lack of a consistent, conceptual,
consensual, or operational definition of CB. Recent total pop-
ulation samples [1•, 2, 3••], which have used psychometrically
evaluated tools to measure and classify CB, appear to have
quite consistent estimates (18.1–18.7%) of CB in adults with
ID known to services. Whilst psychometrically sound infor-
mant measures are helpful in population size samples, they are
not direct measures of the frequency of CBs.
Correlates of Challenging Behaviour
Hastings et al. 2013 [14••] argued that CB is the product of the
interaction between vulnerabilities, maintaining processes,
and impact factors. Psycho-social vulnerabilities include neg-
ative life events, lack of communication skills, impoverished
social networks, lack of meaningful activity, and psychiatric
or mood problems [14••]. Biological vulnerability factors in-
clude health, sensory, and genetic factors [14••]. CB can be
maintained by environmental responses such as other people’s
reactions or internal reinforcement such as pain reduction. CB
can impact on a person’s quality of life and lead to exclusion
from communities and cause harm to self or others. These
effects can then feedback to influence further vulnerability.
For example, dedicated ID services that reduce community
presence for individuals following aggression may then in-
crease social isolation and reduce engagement [14••].
Findings on correlates or “comorbidities” of CB may high-
light populations at risk of developing CB, thus it is impera-
tive that these factors are considered in the design of preven-
tative intervention models. Whilst it is important, that we un-
derstand the correlates of CBs, they only provide a first-level
identification of likely risk factors for CB. Identifying actual
risk factors requires longitudinal research designs.
Previous studies have been criticised for conducting anal-
yses on correlates only for specific populations with CB and
not total population groups [2, 7]. There is little robust litera-
ture to compare correlates of CB [1•] in population samples. In
studies that have considered this issue, some vulnerability
factors appear to have been consistently associated with
higher levels of CB, such as lack of communication skills/
increased severity of ID [1•, 3••, 6, 8], as well as living in
institutional or congregate care settings [1•, 8, 20]. Some pop-
ulation studies have reported association between CB and
younger age [8], but not consistently across different studies.
Research on associations between gender and CB have led to
mixed results, with some studies identifying men at greater
risk of CB [6, 18], some women [1•], and others with no
gender association [3••, 8]. Incontinence [7] and autism [2,
20, 25] have all been reported as correlates of CB in some
specific studies. Epilepsy has previously been identified as a
correlate for CB [27], but not in all recent population-based
samples [1•, 2].
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In the Bowring et al [3••] adult population study, correlates
of CB were explored as well as correlates of specific CBs
(aggressive destructive behaviour, ADB; self-injurious behav-
iour, SIB; stereotyped behaviour, SB)–see Figure 1.
Communication impairments (being non-verbal, having
limited understanding of communication) and having a
severe-profound ID were consistently associated with all four
categories of CB, but there were otherwise different sets of
correlates associated with different behaviours. Mobility prob-
lems, impaired visions, presence of seizures, epilepsy, autism,
presence of another genetic syndrome, no clear speech, having
no daytime engagement, and living in paid or congregate care
were associated with some categories of CB but not consis-
tently across all CB categories.
Other adult population studies that have examined specific
CBs like aggression have found greater prevalence in institu-
tional or congregate care settings and in younger adults [24,
28], higher levels of verbal aggression for those with
mild/moderate ID [24], and higher levels of physical aggres-
sion for those with severe/profound ID [24, 28]. Adult popu-
lation studies that have examined higher levels of SIB have
found associations with lower ability, not living with a family
carer, ADHD, and visual impairments [7]. There has been a
lack of research into the correlates of stereotyped behaviour,
which is concerning given its potential impact on quality of
life.
Further research is required to identify correlates of specific
CBs in population samples. Identifying correlates or vulnera-
bility factors for CB is important for developing preventative
intervention approaches. Whilst several correlates have been
identified for CB, they are not necessarily factors conferring
risk. To identify risk factors requires establishing temporal
precedence [3••, 29], which would require longitudinal de-
signs, which are lacking in adult ID population samples.
Having greater understanding of factors conferring risk of
CB in individuals with ID will help clinicians target these
vulnerability factors for intervention and allow the develop-
ment and testing of tools to identify adults at risk of develop-
ing CB (e.g., [29, 30]).
Combined Effects of Correlates/Risk Factors
Bowring et al. [3••] also considered that CB may be explained
more clearly using the concept of cumulative risk (or the pres-
ence of multiple correlates) as previously proposed by Rutter
[31] as opposed to considering individual correlates acting
independently. Bowring et al. [3••], uniquely for CB popula-
tion research, explored five different ways of combining cor-
relates into “risk” indices to predict CB. These included a
simple dichotomously coded cumulative risk index (CRI)
where participants received a score of 1 if a “risk” indicator
(such as being non-verbal) was present and a score of 0 if
absent, and the number of risk factors out of 20were estimated
for each participant. Other methods included a weighted CRI
considering the intensity of risk exposures, an outcome spe-
cific CRI (i.e., different for each type of CB), a cumulative
domain risk index (CDRI) which involved grouping factors in
conceptually similar domains of risk (e.g., communication
impairments), and a weighted CDRI (using information from
the strength of statistical association with CB). Each of the
methods explored led to similarly effective prediction of CB.
Given that some of the tested methods were more complex in
terms of calculation, Bowring et al. concluded that a simple
count of dichotomously coded CB correlates might represent a
viablemethod for use in clinical practice. However, this as yet,
remains untested.
Challenging Behaviour
Vulnerabilities
Biological Psycho-social
Health / Sensory Communication
Mobility problems 
(SB, CB)
Genetic Factors
Autism (ADB, SB, 
CB)
Non-verbal (SIB, 
SB, ADB, CB)
No clear speech 
(SIB, SB, CB)
Impaired vision 
(SB)
Engagement
Presence of 
epilepsy / seizures 
(SB, SIB, CB)
Presence of other 
syndrome (SB, CB)
Limited 
understanding 
(SIB, SB, ADB, 
CB)
No daytime 
engagement (SIB, 
SB, CB)
Severe/profound 
ID (SIB, SB, ADB, 
CB)
Paid / congregate 
care (SIB, SB, CB)
Fig. 1 Vulnerability factors associated with challenging behaviours from
Bowring et al. 2017 (SIB = Self-injurious behaviour; ADB = Aggressive
destructive behaviour; SB = Stereotyped behaviour; CB = Challenging
behaviour)
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Identifying individuals with ID in community settings,
with multiple risk factors is likely to assist clinicians to
prioritise adults for services [32] and addressing multiple risk
factors is likely to be more effective in the development of
intervention approaches [33]. Having tools that help clinicians
predict the risk of individuals with ID displaying CB, and
specific CBs, will likely be helpful to help identify adults
who would benefit from intervention approaches such as pos-
itive behavioural support [34•, 35, 36•]. Further longitudinal
research is required on the predicative utility of combining
information about correlates/risk factors for CB.
Challenging Behaviour and Mental Health
Problems
As previously suggested, the high prevalence ofMHproblems
and CB, both separately [4, 5•] and concurrently [37] in adults
with ID, is generally recognised. In addition, existing research
suggests that mental ill health may be a correlate of CB.
However, there is less certainty regarding exactly how and
why CB and MH problems are related in adults with ID [38,
39].
Some researchers have argued that MH and CB in people
with ID are independent constructs. Tsiouris and colleagues
[40] for example, found no statistical difference in CB be-
tween outpatients “with depression” and those “without de-
pression” in a cross-sectional analysis of ratings from the
Clinical Behaviour Checklist for Persons with ID. Sturmey
et al. [41] additionally concluded that CBs could not be
viewed as depressive equivalents in their similar correlational
study as there were no particular CBs reliably associated with
depression. Melville et al. [42] surmised that CB was not
indicative of depression because the measurement items relat-
ed to depression and CBwere located in different factors of an
analysis of the Psychiatric Present State-Learning Disabilities
Examination Scale. Other researchers also found that CB was
not associated with MH problems [43, 44].
In contrast, other studies have found associations between
CB and mental health problems. Felce and colleagues [45]
employed moderated multiple regression techniques to ana-
lyse the characteristics of people with ID in primary care set-
tings. Here they detected a significant relationship between
MH problems and CB, which was more pronounced in people
with lower levels of adaptive behaviour. Replicating elements
of this robust study in secondary care services, Painter et al.
[46] also found the severity of MH problems to be associated
with measures of aggression, self-injurious behaviours, and
overall ratings of CB, again finding the strongest associations
in participants with more severe ID. Poppes et al. [47] also
found higher rates of CB in those participants already diag-
nosed with a MH condition when focusing solely on individ-
uals with profound ID.
Thus, existing research is inconclusive in relation to an
association between CB and MH in adults with ID when the
two constructs are examined in the context of correlation/
regression designs. Whilst this may vary according to the
combination of specific type of CB and MH conditions ex-
amined [48], there is however, some consistent evidence that
CB and MH globally are more strongly associated in those
with more severe to profound ID. This pattern of findings is
consistent with a hypothesis that CB may be indicators of
underlying MH problems in those with more severe ID
[45–47].
In addition to these correlational, cross-sectional designs,
cluster analysis has been used as a means of identifying ho-
mogenous sub-groups of individuals with ID [49, 50]. These
studies provide a different way to examine associations be-
tween MH and CB: Do they tend to co-occur in groups of
individuals identified statistically as similar? Crocker et al.
[51] for example, gathered data on 296 individuals with
mild-moderate ID using a range of clinical measures and case
note analysis. After further limiting the sample to include on
those who displayed outward aggression, they found six dis-
tinct clusters. One was typified by low levels of CB and low
levels of MH problems, with a second yielding relatively high
levels of both variables. These findings were mirrored in a
more recent study by Painter et al. [52] who analysed data
gathered from 1692 adults with a broad range of ID and asso-
ciated needs. Using demographic information in conjunction
with a battery of six different clinical measures including gen-
eral ability/disability, overall risk, severity of MH problems,
CB, autism symptoms, and physical health problems. Painter
and colleagues also identified six statistically robust group-
ings. Low CB and MH problems clustered together in one
sub-group, and a contrasting group had high levels of CB
and MH problems. Thus, CB and MH problems do seem to
co-occur in adults with ID.
Due to a range of limitations, none of the existing research
studies allowing an examination of the association between
CB and MH can be considered definitive. The main limita-
tions include fundamental differences in diagnostic constructs
in the field of ID [42, 53], inconsistent definitions of CB (as
mentioned earlier, and [54]). overlap between these two prob-
lems [55•], and the practical challenges of categorical diagno-
ses in both clinical and research settings [56]. In addition to
these conceptual challenges, much of the research has been
adversely affected by methodological limitations including
modest sample sizes [42], cross-sectional designs [57], and
tautological issues such as studying people with ID already
diagnosed with a psychiatric condition to elicit the presenta-
tion of MH problems in people with ID [5•]. Latterly, some of
the statistical approaches employed have been questioned due
to a failure to control for confounding variables, the use of
techniques unsuited to categorical data, and a failure to vali-
date (confirm) exploratory factor analyses [38, 42].
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Therefore, although we argue that MH and CB interact in
some way, we acknowledge that some ambiguity remains and
all that three of Emerson’s [58] concisely articulated hypoth-
eses remain plausible:
& That MH problems might serve to maintain pre-existing
CB. For example, a depressed person with ID might lack
the motivation to engage socially and may equally have
learned that exhibiting certain behaviours typically leads
to their isolation from others. In this way, their CBs may
be reinforced.
& Secondly that, in individuals who struggle to express their
emotions (due to their ID), CBs may be secondary features
of MH problems. For instance, somatic symptoms of de-
pression (aches and pains) could result in sleep distur-
bance, agitation, and other CBs.
& Finally, in individuals with more severe ID, CBs may be
atypical manifestations of a mental health problem.
Although the putative association or “comorbidity” be-
tween CB and MH was identified several decades ago, the
amount and quality of research addressing how or why they
may be related remains very limited. Thus, this issue requires
future, high quality, and theoretically informed, research
attention.
The Association between CB and Psychotropic
Medication
Recent population studies have revealed high prevalence of
psychotropic medication use in adults with ID. Henderson
et al. [59] found a 49.1% prevalence rate of psychotropic
medication use with a prevalence rate of antipsychotic drug
use of 23.2%. Similarly, Sheehan et al. [23•] found a 49%
prevalence of psychotropic medication use with 21% of par-
ticipants prescribed with antipsychotic medication. These
studies used population-based samples, but identified their
participants from primary care services. Sheehan et al. [23•]
suggest they may have over-estimated prevalence of prescrib-
ing due to difficulties identifying adults with mild ID fromGP
records. Bowring et al. [60] considered prevalence of psycho-
tropic medication use from a population sample identified
from multiple routes, not primary care. In this study, the use
of psychotropic medication was 37.73% with 21.89% pre-
scribed antipsychotic medication [60].
Research has indicated that individuals with ID and CB are
prescribed with more psychotropic medications than those
without CB [60–67], despite little evidence of clinical benefit
[68–70] where mental health issues are not present. There are
significant side effects of these medications with weight gain,
somnolence, metabolic syndromes, and behavioural impacts
being reported [66, 70–74]. High rates of psychotropic
medication use (49% [23]; 38% [60]) are a major issue for
people with ID and CB, and medication reduction should be a
priority area for services.
A Revised Framework Model for CB
Hastings and colleagues’ framework for organising the more
robust findings in the research literature about the develop-
ment and maintenance of CB [14••] was written 6 years ago.
Thus, we have returned to this pragmatic framework to con-
sider how more recent research findings may need to be
incorporated.
Firstly, given recent research on vulnerability factors, we
have extended the list of potential correlates, and presented
these within a biopsychosocial framework (Figure 2).
Secondly, given Bowring et al.’s [3••] exploration of com-
bining correlates/risk factors, we have also represented this in
Figure 2 to emphasise that individuals are likely to be
explosed to multiple vulnerability factors. The inclusion of
this recognition of multiple factors acting together also high-
lights some questions for future research. It may be that some
risk factors combine to incrementally add to the risk of CB,
but some risk factors might only contribute to the develop-
ment of CB in the presence of other risk factors (i.e., an inter-
action) [75]. Research on combining risk factors is important
as it should lead to the development of clinical tools that help
to assess and understand individual risk and thus inform pre-
ventative intervention.
Thirdly, we have added positive automatic reinforcement
to maintaining processes, alongside pain, indicating CB can
be maintained by internal reinforcement as well as environ-
mental reinforcement by other peoples’ responses (such as
through attention, tangible, or escape contingencies).
Fourthly, we represented the additional use of psychotropic
medication as an outcome of CB and have included the effects
of psychotropic medication as feeding back into additional
vulnerability for CB. The physical and behavioural side ef-
fects described above [66, 70–74] may also have a cyclical
impact on biological vulnerabilities for CB, hence we have
included a feedback loop into biological vulnerabilty factors.
Discussion
Within this paper, we have presented recent research on the
prevalence and correlates of CB in adults with ID. There has
been some consistency in the prevalence of CB in recent pop-
ulation studies for adults with ID [1•, 2, 3••]. Further research
is required in population samples that additionally examines
prevalance of specific CBs using classification tools with
clear, operational definitions of CB.
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Understanding correlates of CB is important for services to
target interventions on vulnerability factors, such as develop-
ing communication pathways for adults with communication
impairments. There has been a lack of robust research on
correlates in population samples and even less investigation
into correlates of specific CBs. Further longitudinal studies are
required to investigate risk factors of adults with ID develop-
ing CBs. It is likley that the risk of CB will increase with
multiple risk factors present. From future research, risk tools
can be developed to identify adults who should be prioritised
for services and understand factors to be tackled in preventa-
tive service models.
The relationship between MH, CB, and the subsequent
increased likelihood of psychotropic medication use was de-
scribed. It was concluded that the relationship between CB
and MH is not yet fully understood, but potentially bi-direc-
tional. Further, theoretically informed research is needed in
population samples to investigate the interplay between MH
and CB and approaches to reduce medication use in adults
with ID.
Conclusions
The prevalance of CB may be approximately 1 in 5–6 adults
with ID known to services, and can have a major impact on
quality of life. Interventions for CB and MH need to consider
relevant strategies that tackle vulnerabilities, maintaining pro-
cesses, and impact factors for adults with ID as outlined in the
revised CB framework model. Interventions will, therefore,
need to focus on multi-element responses [34•, 35, 36•].
Future development of tools that consider the cumulative im-
pact of risk factors will be very helpful in designing preven-
tative intervention models. The prescribing of psychotropic
VULNERABILITY 
FACTORS
IMPACTMAINTAINING 
PROCESSES
BIOLOGICAL:
• Addional syndromes
• Ausm
• Physical health issues 
(e.g. pain)
• Epilepsy / seizures
• Sensory impairments
PSYCHOSOCIAL:
• Lack of communicaon 
skills
• Negave life events
• Family stress
• Mental health issues
• Lack of meaningful 
acvity
• Impoverished social 
networks
• Instuonalised 
accommodaon
• Socio-economically 
disadvantaged
BIOLOGICAL:
• Eﬀects of psychotropic 
medicaon
• Harm to self
PSYCHOSOCIAL:
• Exclusion
• Harm to others
• Mental health issues
Challenging 
Behaviour
• Pain reducon
• Posive automac 
reinforcement 
• Other people's 
behaviours 
Fig. 2 A revised (building on Hastings et al. 2013) framework for understanding challenging behaviour. Adapted with permission from the International
Journal of Positive Behavioural Support
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medication to manage CB, where there are no MH issues, is
common and given the lack of evidence for effectiveness
should be reviewed in individual cases [76].
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